MoonLake Immunotherapeutics (MLTX) Stock Price
$47.2 0.7%
to add to portfolio
AI Score
-
Alternative
7 -
Fundamental
6 -
Technical
6
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on MoonLake Immunotherapeutics, AI stock picks, stock alerts and much more.
MLTX AI Stock Analysis
AI stock analysis for MLTX is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like MoonLake Immunotherapeutics (MLTX) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
MoonLake Immunotherapeutics (MLTX) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of MoonLake Immunotherapeutics (MLTX), currently trading at $47.2, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About MLTX
-
MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies.
-
Symbol
MLTX
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
3B
Similar Stocks
 |
Catalyst Pharmaceuticals CPRX |
$21.7 0.4% |
6 |
 |
Inovio Pharmaceuticals INO |
$2.04 3.6% |
3 |
 |
Moderna MRNA |
$27.59 1.6% |
3 |
 |
Anavex Life Sciences AVXL |
$9.22 2.7% |
6 |
 |
BridgeBio Pharma BBIO |
$43.18 3.7% |
7 |
News
MLTX Alternative Data
Web Traffic
MoonLake Immunotherapeutics receives an estimated 4119 monthly visitors to moonlaketx.com.
-
Web Traffic
4119
-
Change from Previous Month
11.3%
-
3 Month Change
13.6%
-
YoY Change
13.6%
LinkedIn Followers
6,910 are following MoonLake Immunotherapeutics on LinkedIn, up by 6.9% over the last month.
-
LinkedIn Followers
6910
-
Daily Change
0.2%
-
1 Month Change
6.9%
-
3 Month Change
17.5%
Job Postings
MoonLake Immunotherapeutics has an estimated 10 open job postings, which is down -9.1% over the last month.
-
Job Postings
10
-
Daily Change
0%
-
1 Month Change
9.1%
-
3 Month Change
42.9%
-
YoY Change
42.9%
LinkedIn Employees
According to LinkedIn, MoonLake Immunotherapeutics has 123 employees, up by 6% over the last month.
-
LinkedIn Employees
123
-
Daily Change
0%
-
1 Month Change
6%
-
3 Month Change
10.8%
-
YoY Change
10.8%
Reddit Mentions
MoonLake Immunotherapeutics has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Twitter Followers
MoonLake Immunotherapeutics has 117 Twitter Followers on its main Twitter (also known as X) account, which is up by 5.4% over the last month.
-
Twitter Followers
117
-
Daily Change
0%
-
1 Month Change
5.4%
-
3 Month Change
7.3%
-
YoY Change
7.3%
News Mentions
MoonLake Immunotherapeutics was mentioned 1 times in the news yesterday.
-
News Mentions
1
-
Daily Change
50%
-
1 Month Change
0%
-
3 Month Change
0%
MLTX Financials
MLTX Key Metrics
-
Total Revenue
$101.9K
-
Net Income
-$45.6M
-
Earnings per Share
$1.16
-
Free cash flow
-$117B
-
EBITDA
-$48.3M
-
EBITDA Ratio
-474.021
-
Total Assets
$477.9B
MLTX 2-year Revenue & Income
MLTX 2-year Free Cash Flow
MLTX Technicals
MLTX SMA
MLTX RSI
FAQ
What's the current price of MoonLake Immunotherapeutics (MLTX) Stock?
The price of an MoonLake Immunotherapeutics (MLTX) share is $47.2.
What's the market cap of MoonLake Immunotherapeutics?
The current market cap of MoonLake Immunotherapeutics is 3B.
Should I buy or sell MLTX?
MoonLake Immunotherapeutics shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, MoonLake Immunotherapeutics is better viewed as a hold or accumulate position while waiting for further developments.
Is MoonLake Immunotherapeutics a good investment?
The current analysis of MoonLake Immunotherapeutics' fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in MoonLake Immunotherapeutics' portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy MoonLake Immunotherapeutics (MLTX) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for MoonLake Immunotherapeutics stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to MoonLake Immunotherapeutics (MLTX) that investors often compare it to?
MoonLake Immunotherapeutics (MLTX) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.
What is the forecast for MoonLake Immunotherapeutics' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast MoonLake Immunotherapeutics' stock price to be around $50.74 in 2026. Starting from the current price of $47.2, this represents a 7.5% change in price, indicating a bullish outlook for the stock.
How to buy MoonLake Immunotherapeutics (MLTX) Stock?
MoonLake Immunotherapeutics stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy MoonLake Immunotherapeutics shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.